Weekly docetaxel and gemcitabine in previously treated metastatic esophageal squamous cell carcinoma

AIM: To assess the efficacy and safety of weekly docetaxel plus a fixed-dose rate (FDR) of gemcitabine in metastatic esophageal squamous cell carcinoma (SCC). METHODS: A multi-center, open-label, prospective phase II study was designed. Thirty-three esophageal SCC patients with documented progressio...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:World J Gastroenterol
Päätekijät: Lee, Min-Young, Jung, Ki Sun, Kim, Hae Su, Lee, Ji Yun, Lim, Sung Hee, Kim, Moonjin, Jung, Hyun Ae, Kim, Sung Min, Sun, Jong Mu, Ahn, Myung-Ju, Lee, Jeeyun, Park, Se Hoon, Yi, Seong Yoon, Hwang, In Gyu, Lee, Sang-Cheol, Ahn, Hee Kyung, Lim, Do Hyoung, Lee, Soon Il, Park, Keon Woo
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Baishideng Publishing Group Inc 2015
Aiheet:
Prospective Study
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4394089/
https://ncbi.nlm.nih.gov/pubmed/25892878
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v21.i14.4268
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia